Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis

Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Molecular. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Molecular. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Molecular. Rio de Janeiro, RJ. Brasil.
Universidade do Estado do Rio de Janeiro. Departamento de Gastroenterologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Molecular. Rio de Janeiro, RJ. Brasil.
Universidade do Estado do Rio de Janeiro. Departamento de Gastroenterologia. Rio de Janeiro, RJ, Brasil.

Abstract

Patients undergoing hemodialysis are at risk of infection with both hepatitis B virus (HBV) and hepatitis C virus (HCV). Occult HBV infection is usually associated with low levels of HBV and is frequently detected in HCV-infected patients. The aims of the present study were to compare the prevalence of occult HBV infection among anti-HCV-positive and anti-HCV-negative patients undergoing hemodialysis, and characterize the molecular patterns of HBV isolates from patients with occult infection.

Keywords in Portuguese

Hepatite B
Hemodiálise
Infecção oculta

Keywords

anti-HCV
HBV-DNA
hemodialysis
hepatitis B
occult infection

Publisher

Wiley

Citation

MOTTA, Jorge S. et al. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. Journal of Gastroenterology and Hepatology, v.24, p.101-106, 2010.

DOI

10.1111/j.1440-1746.2009.05972.x

ISSN

0815-9319

Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/25405

Type

Copyright

Restricted access

Embargo date

2030-01-01

Collections

Share

Statistics

Metadata

Author

Affilliation